Inhibitory effects of luteolin‑4'‑O‑β‑D‑glucopyranoside on P2Y12 and thromboxane A2 receptor‑mediated amplification of platelet activation in vitro

Int J Mol Med. 2018 Jul;42(1):615-624. doi: 10.3892/ijmm.2018.3634. Epub 2018 Apr 19.

Abstract

Platelet activation and subsequent accumulation at sites of vascular injury are central to thrombus formation, which is considered to be a trigger of several cardiovascular diseases. Callicarpa nudiflora (C. nudiflora) Hook is a traditional Chinese medicinal herb for promoting blood circulation by removing blood stasis. In our previous study, several compounds extracted from this herb, including luteolin‑4'‑O‑β‑D‑glucopyranoside (LGP), were revealed to exert inhibitory effects on adenosine diphosphate (ADP)‑induced platelet aggregation. The aim of present study was to confirm these antiplatelet effects and elucidate the potential mechanisms. Using a platelet‑aggregation assay, it was revealed that LGP significantly inhibited platelet aggregation induced by ADP, U46619 and arachidonic acid. It was also found that LGP exhibited marked inhibitory effects on the activation of αIIbβ3 integrin, the secretion of serotonin from granules, and the synthesis of thromboxane A2. In addition, the results showed that LGP suppressed Ras homolog family member A and phosphoinositide 3‑kinase/Akt/glycogen synthase kinase 3β signal transduction. Data from a radiolabeled ligand‑binding assay indicated that LGP exhibited apparent competing effects on thromboxane receptor (TP) and P2Y12 receptors. In conclusion, the data presented here demonstrated that LGP, a natural compound from C. nudiflora Hook, inhibited the development of platelet aggregation and amplification of platelet activation. These inhibitory effects may be associated with its dual‑receptor inhibition on P2Y12 and TP receptors.

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Adenosine Diphosphate / pharmacology
  • Animals
  • Arachidonic Acid / pharmacology
  • Bridged Bicyclo Compounds, Heterocyclic / metabolism
  • Fatty Acids, Unsaturated / metabolism
  • Female
  • Glucosides / chemistry
  • Glucosides / pharmacology*
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Hydrazines / metabolism
  • Luteolin / chemistry
  • Luteolin / pharmacology*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Platelet Activation / drug effects*
  • Platelet Aggregation / drug effects
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2Y12 / metabolism*
  • Receptors, Thromboxane A2, Prostaglandin H2 / metabolism*
  • Serotonin / metabolism
  • Signal Transduction / drug effects
  • Thromboxane A2 / biosynthesis
  • Tritium
  • rhoA GTP-Binding Protein / metabolism

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Fatty Acids, Unsaturated
  • Glucosides
  • Hydrazines
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Receptors, Purinergic P2Y12
  • Receptors, Thromboxane A2, Prostaglandin H2
  • Tritium
  • Arachidonic Acid
  • Serotonin
  • Thromboxane A2
  • Adenosine Diphosphate
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • SQ 29548
  • Phosphatidylinositol 3-Kinases
  • Glycogen Synthase Kinase 3 beta
  • Proto-Oncogene Proteins c-akt
  • rhoA GTP-Binding Protein
  • Luteolin